MMP9 and laryngeal carcinoma: Weiyi Wang [36] found that dihydroartemisinin could inhibit STAT3 activation, down-regulate MMP-9, and affect the invasion and metastasis of cancer stem cells (CSCs) in laryngeal cancer.